Cohort 2025↗

9Bio Therapeutics
Engineering next-generation cancer therapies by reprogramming proteins to act selectively within tumors
Improving the efficacy and developability of small-format soluble TCRs to address cellular heterogeneity in diseases

Building a company, exploring the program or looking to contribute? Tell us what you have in mind.